Sometimes a positive can be a negative. That’s the word from a few IndyCar Series teams who weren’t delighted to see the ...

A new feature in the fledgling relationship between the IndyCar Series and FOX is the deployment of “Ghost Car” technology.

The newly formed division aims to work with leading motorsport teams within NASCAR, Formula 1, IndyCar, and IMSA. Co-chairs Mark Walter and Thomas Tull spearheaded the founding of TWG Motorsports ...

Download the latest executable jar file (gps-overlay-on-video.jar) from here. It requires to have a java installation to run the application as follows: java --add ...

The NVIDIA overlay might not work, stopping users from accessing in-game features even when using the correct shortcut keys. This issue is mainly due to a problem with GeForce Experience, which stops ...

Heart of Racing’s Aston Martin Valkryie AMR-LMH will have a more distinct sound to it when the car makes its IMSA WeatherTech SportsCar Championship debut in next month’s Mobil 1 Twelve Hours ...

Anthony Bartone said competing in the IMSA WeatherTech SportsCar Championship is “the next rung on the ladder” for Bartone Bros. Racing, expressing his desire to mount a full-season campaign ...

Heart of Racing has outlined their IMSA and FIA WEC driver line-ups ahead of their nearing Aston Martin Valkyrie Hypercar programme endeavour. The Heart of Racing (THOR) will run Aston Martin’s ...

Fans need to see the competitive passion if IMSA wants to hit top dead center with some real torque. When Sebastien Bourdais lambasted IMSA for its post-race demotion of Tower Motorsports from ...

The Iron Dames has retained Michelle Gatting, Rahel Frey and Sarah Bovy for the remaining four IMSA Endurance Cup races of the 2025 season. As having competed in the 2024 IMSA SportsCar Championship, ...

AutoNET IMSA - Winners again Posted: January 31, 2025 | Last updated: January 31, 2025 Porsche Penske Motorsport has clinched its second consecutive victory at the 24 Hours of Daytona. Last year's ...

IMSA-101 is under clinical development by ImmuneSensor Therapeutics and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to GlobalData, Phase II drugs for ...